MiNK Therapeutics Inc. (INKT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

MiNK Therapeutics Inc.

NASDAQ: INKT · Real-Time Price · USD
15.02
-0.44 (-2.85%)
At close: Oct 03, 2025, 3:59 PM
14.50
-3.43%
After-hours: Oct 03, 2025, 07:06 PM EDT

MiNK Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.78M -22.46M -27.99M -30.21M
Depreciation & Amortization
215.44K 204.62K 121.75K 77.96K
Stock-Based Compensation
1.81M 3.86M 3.03M 1.74M
Other Working Capital
1.64M 4.81M 6.11M 3.89M
Other Non-Cash Items
-1.26M -266.78K -2.79M 12.18M
Deferred Income Tax
n/a n/a n/a -355.51K
Change in Working Capital
459.73K 2.9M 8.77M 3.74M
Operating Cash Flow
-9.56M -15.76M -18.87M -12.83M
Capital Expenditures
-4 -73.56K -250.05K -248.98K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a -73.56K -250.05K -248.98K
Debt Repayment
5M n/a n/a 9.46M
Common Stock Repurchased
n/a -477.64K -157.19K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
19.99K 70.47K 1.59K 150.00
Financial Cash Flow
10.82M -407.17K -155.6K 49.26M
Net Cash Flow
1.21M -16.27M -19.25M 36.2M
Free Cash Flow
-9.56M -15.84M -19.12M -13.08M